Welcome to the Kristine Yaffe Group!
Our mission is to investigate the risk and resilience factors for cognitive aging and dementia, especially to identify opportunities for prevention.
Our Director
Learn about Dr. Kristine Yaffe, and her novel work in the epidemiology of dementia and cognitive aging.
What We Do
Our team is dedicated to protecting cognitive health across the lifespan. We pioneer population-based research identifying modifiable risk factors for dementia and cognitive aging, including their biological connections, to develop prevention strategies.
Latest Breakthrough
Published in The Lancet, our new research shows that midlife plasma biomarkers (Aβ42, Aβ40, and p-tau217) are associated with accelerated cognitive decline. These findings indicate that blood tests may offer a means of early detection for potential AD.